Pasithea Therapeutics (KTTA) Gains from Investment Securities (2021 - 2024)
Historic Gains from Investment Securities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$1406.0.
- Pasithea Therapeutics' Gains from Investment Securities fell 10254.22% to -$1406.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $62807.0, marking a year-over-year increase of 21166.68%. This contributed to the annual value of $77806.0 for FY2024, which is 23833.41% up from last year.
- Pasithea Therapeutics' Gains from Investment Securities amounted to -$1406.0 in Q4 2024, which was down 10254.22% from $17649.0 recorded in Q3 2024.
- Over the past 5 years, Pasithea Therapeutics' Gains from Investment Securities peaked at $600000.0 during Q1 2022, and registered a low of -$2.6 million during Q4 2021.
- In the last 4 years, Pasithea Therapeutics' Gains from Investment Securities had a median value of $8121.5 in 2024 and averaged -$202313.4.
- Within the past 5 years, the most significant YoY rise in Pasithea Therapeutics' Gains from Investment Securities was 13922.35% (2024), while the steepest drop was 15700.02% (2024).
- Over the past 4 years, Pasithea Therapeutics' Gains from Investment Securities (Quarter) stood at -$2.6 million in 2021, then soared by 62.09% to -$980509.0 in 2022, then soared by 105.64% to $55307.0 in 2023, then plummeted by 102.54% to -$1406.0 in 2024.
- Its last three reported values are -$1406.0 in Q4 2024, $17649.0 for Q3 2024, and $35622.0 during Q2 2024.